Last reviewed · How we verify
NCT03182205
Autonomic and Hemodynamic Responses to Inspiratory Muscle Exercise in Pre Hypertensive and Hypertensive Individuals
NA trial testing IME in Prehypertension in 18 participants. Completed in 1 February 2018.
1 February 2018
Quick facts
| Lead sponsor | Federal University of Juiz de Fora |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 26 June 2017 |
| Primary completion | 1 February 2018 |
| Estimated completion | 1 February 2018 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- IME
- Sham IME
Conditions studied
- Prehypertension — all drugs for Prehypertension →
- Hypertension — all drugs for Hypertension →
Sponsor
Federal University of Juiz de Fora
Who can join
Adults 18 to 80, male only, with Prehypertension or Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the autonomic and hemodynamic responses triggered by inspiratory muscle exercise in prehypertensive and hypertensive individuals. The reason that leads us to this study refers to clinical relevance for individuals with high blood pressure levels, since this type of exercise can act as a important nonpharmacological agent for arterial pressure control. In addition, this study aims to elucidate the mechanisms involved in cardiovascular responses to inspiratory muscle exercise and, consequently, provide safety in the prescription of these for this population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03182205
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prehypertension
Currently open trials in the same condition.
- NCT07372729 — Smartwatch-based Intervention for Cardiovascular Health (SWITCH) · NA · recruiting
- NCT06762262 — Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients · NA · active not recruiting
- NCT05469503 — Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure · NA · active not recruiting
- NCT06595251 — Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study · recruiting
- NCT06596265 — Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study · recruiting
Other Federal University of Juiz de Fora trials
Trials by the same sponsor.
- NCT03914924 — Effects of an Exercise and Lifestyle Education Program for People With Diabetes and Prediabetes · NA · active not recruiting
- NCT03973190 — Evaluation of Bone Quality and Primary and Secondary Stability of Implants Installed in Alveolar Regeneration Area by Th · NA · unknown
- NCT03237949 — Text Messaging and Telephone Counseling for Supporting Post-discharge Quit Attempts · NA · completed
- NCT03132597 — Impact of Teaching "Meditation Techniques" on the Mental Health and Quality of Life of Medical Students · NA · completed
- NCT03143699 — The Effect of Immediate Feedback on Long-term Blood Pressure Measurement Skills: a Randomized Controlled Trial · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03182205 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal University of Juiz de Fora
- Last refreshed: 22 February 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03182205.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing